Scopus BioPharma Inc (SCPS)
0.0021
0.00 (0.00%)
USD |
OTCM |
May 15, 11:32
Scopus BioPharma Shareholders Equity (Quarterly): -9.452M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -9.452M |
| March 31, 2023 | -6.947M |
| December 31, 2022 | -6.564M |
| September 30, 2022 | -5.504M |
| June 30, 2022 | -3.698M |
| March 31, 2022 | -0.5304M |
| December 31, 2021 | 4.017M |
| September 30, 2021 | 1.794M |
| Date | Value |
|---|---|
| June 30, 2021 | -1.984M |
| March 31, 2021 | 4.148M |
| December 31, 2020 | -1.831M |
| September 30, 2020 | -2.549M |
| December 31, 2019 | -0.0829M |
| June 30, 2019 | 1.099M |
| March 31, 2019 | 0.6409M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-9.452M
Minimum
Jun 2023
4.148M
Maximum
Mar 2021
-2.006M
Average
-1.908M
Median
Shareholders Equity (Quarterly) Benchmarks
| Humanigen Inc | -49.72M |
| Item 9 Labs Corp | 52.65M |
| Cantabio Pharmaceuticals Inc | -1.889M |
| Affymax Inc | -- |
| Statera BioPharma Inc | -10.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.4976M |
| Total Liabilities (Quarterly) | 11.00M |